Literature DB >> 11238140

Management of stage 1 endometrial carcinoma. Postoperative radiotherapy is not justified in women with medium risk disease.

M P Burger.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11238140      PMCID： PMC1119775          DOI： 10.1136/bmj.322.7286.568

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists.

Authors:  R W Naumann; R V Higgins; J B Hall
Journal:  Gynecol Oncol       Date:  1999-10       Impact factor: 5.482

2.  Surgical staging of uterine cancer: an analysis of perioperative morbidity.

Authors:  J W Orr; R W Holloway; P F Orr; J L Holimon
Journal:  Gynecol Oncol       Date:  1991-09       Impact factor: 5.482

3.  An analysis of approaches to the management of endometrial cancer in North America: a CTF study.

Authors:  T Maggino; C Romagnolo; F Landoni; E Sartori; P Zola; A Gadducci
Journal:  Gynecol Oncol       Date:  1998-03       Impact factor: 5.482

4.  Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.

Authors:  W T Creasman; C P Morrow; B N Bundy; H D Homesley; J E Graham; P B Heller
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

5.  Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Authors:  C L Creutzberg; W L van Putten; P C Koper; M L Lybeert; J J Jobsen; C C Wárlám-Rodenhuis; K A De Winter; L C Lutgens; A C van den Bergh; E van de Steen-Banasik; H Beerman; M van Lent
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

Review 6.  Complete surgical staging in endometrial cancer provides prognostic information only.

Authors:  D G Petereit
Journal:  Semin Radiat Oncol       Date:  2000-01       Impact factor: 5.934

7.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

Authors:  C P Morrow; B N Bundy; R J Kurman; W T Creasman; P Heller; H D Homesley; J E Graham
Journal:  Gynecol Oncol       Date:  1991-01       Impact factor: 5.482

8.  Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse.

Authors:  I Ackerman; S Malone; G Thomas; E Franssen; J Balogh; A Dembo
Journal:  Gynecol Oncol       Date:  1996-02       Impact factor: 5.482
  8 in total
  1 in total

1.  A tool to balance benefit and harm when deciding about adjuvant therapy.

Authors:  A M Knops; A Goossens; M P M Burger; L J A Stalpers; D T Ubbink
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.